Loblaw welcomes Shoppers Drug Mart shareholders' approval of acquisition
BRAMPTON, ON, Sept. 12, 2013 /CNW/ - Loblaw Companies Limited (TSX: L)
welcomed the decision by shareholders of Shoppers Drug Mart Corporation to
approve Loblaw's acquisition of Canada's leading pharmacy retailer at a
special Shoppers Drug Mart shareholders' meeting held in Toronto today.
"We are very pleased that Shoppers Drug Mart shareholders have overwhelmingly
decided to support Loblaw's acquisition, which brings together two of the most
recognized and trusted names in Canadian retailing to create the leading
Canadian retailer," said Galen G. Weston, Executive Chairman of Loblaw. "The
combination of Loblaw and Shoppers Drug Mart will transform the Canadian
retail landscape by delivering more choice, service, value and convenience for
Shoppers Drug Mart shareholders were asked to vote on a special resolution
approving Loblaw's acquisition of all outstanding common shares of Shoppers
Drug Mart in accordance with the definitive agreement entered into on July 14,
2013. The resolution was approved by 99.89% of the votes cast by Shoppers Drug
Closing of the transaction remains subject to court approval and the customary
competition review process. "Given the complementary nature of the two
companies' businesses and the intensely competitive Canadian retail market, we
remain confident the transaction will be approved," commented Mr. Weston.
"Discussions with the Competition Bureau are ongoing and proceeding as
expected. We are working with the Bureau to expedite the process. We continue
to expect to complete the transaction by the end of the first quarter of 2014."
About Shoppers Drug Mart
Shoppers Drug Mart is one of the most recognized and trusted names in Canadian
retailing. Shoppers Drug Mart is the licensor of full-service retail drug
stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec).
With 1,244 Shoppers Drug Mart and Pharmaprix stores operating in prime
locations in each province and two territories, the Company is one of the most
convenient retailers in Canada. Shoppers Drug Mart also licenses or owns 57
medical clinic pharmacies operating under the name Shoppers Simply Pharmacy
(Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations
operating as Murale. As well, the Company owns and operates 62 Shoppers Home
Health Care stores, making it the largest Canadian retailer of home health
care products and services. In addition to its retail store network, the
Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of
specialty drug distribution, pharmacy and comprehensive patient support
services; and MediSystem Technologies Inc., a provider of pharmaceutical
products and services to long-term care facilities.
About Loblaw Companies Limited
Loblaw Companies Limited, a subsidiary of George Weston Limited, is Canada's
largest food retailer and a leading provider of drugstore, general merchandise
and financial products and services. Loblaw is one of the largest private
sector employers in Canada. With more than 1,000 corporate and franchised
stores from coast to coast, Loblaw and its franchisees employ approximately
134,000 full-time and part-time employees. Through its portfolio of store
formats, Loblaw is committed to providing Canadians with a wide, growing and
successful range of products and services to meet the everyday household
demands of Canadian consumers. Loblaw is known for the quality, innovation and
value of its food offering. It offers Canada's strongest control (private)
label program, including the unique President's Choice®, no name® and Joe
Fresh® brands. In addition, the Company makes available to consumers
President's Choice Financial® services and offers the PC® points and PC
Plus™ loyalty program. For more information, visit Loblaw's website at
www.loblaw.ca and Loblaw's issuer profile at www.sedar.com.
Certain statements in this news release are forward-looking information within
the meaning of applicable securities legislation including, but not limited
to, statements relating to the expected closing date of the transaction and
certain strategic benefits expected to result from the transaction.
Forward-looking information is based on a number of assumptions and is subject
to a number of risks and uncertainties, many of which are beyond Loblaw's
control, that could cause actual results and events to differ materially from
those that are disclosed in or implied by such forward-looking information.
There can be no assurance that the transaction will occur or that the
anticipated strategic benefits and operational, competitive and cost synergies
will be realized. The transaction is subject to various regulatory approvals,
including approvals under the Competition Act (Canada) and by the TSX, and the
fulfillment of certain conditions, and there can be no assurance that any such
approvals will be obtained and/or any such conditions will be met. Loblaw does
not undertake any obligation to update such forward-looking information,
whether as a result of new information, future events or otherwise, except as
expressly required by applicable law.
SOURCE Loblaw Companies Limited
Investor Enquiries, contact: Jonathan Ross Investor Relations (905) 861-2153
Media Enquiries, contact: Julija Hunter Vice President, Public Relations
(905) 861-2437 firstname.lastname@example.org
To view this news release in HTML formatting, please use the following URL:
CO: Loblaw Companies Limited
NI: RET FDR MNA
-0- Sep/12/2013 16:00 GMT
Press spacebar to pause and continue. Press esc to stop.